Heart, Lung and Circulation
Original Article| Volume 25, ISSUE 12, P1203-1209, December 2016

Routine Use of Fluoroscopic-Guided Femoral Arterial Puncture to Minimise Vascular Complication Rates in CTO Intervention: Multi-centre UK Experience


      Chronic total occlusion (CTO) revascularisation has a crucial role in contemporary percutaneous coronary intervention (PCI). Procedural success is influenced by disease complexity, calcific burden and patient characteristics but has substantially improved with the implementation of novel hybrid strategies. However, vascular-access related complications remain a cause of morbidity and mortality. This study aimed to assess the effectiveness of fluoroscopic-guided femoral arterial puncture to minimise this risk during CTO PCI.


      Standardised data were retrospectively collected from four high-volume UK CTO centres between September 2011 and November 2013. Demographic, clinical and procedural data (vascular access site, sheath size, anticoagulation use) was collated. The anatomical location of the femoral puncture in relation to the femoral bifurcation, femoral head position and inferior epigastric artery were recorded. Adverse events related to vascular access were documented.


      A total of 528 patients were included (676 femoral punctures) with the majority being male (n=432, 81.8%). Large sheaths (8F) were used in 81.2% of cases. Fluoroscopy-enabled punctures were made in the ‘safe zone’ in over > 93% of cases. Vascular closure devices (VCD) were used in 88.3% of cases. The adverse event rate per puncture was 0.89%.


      This study demonstrates an extremely low incidence of vascular-access complications in CTO PCI when fluoroscopic guidance is used to obtain femoral arterial access by default radial operators.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Muller D.W.
        • Samir K.J.
        • Ellis S.G.
        • Topol E.J.
        Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures.
        Am J Cardiol. 1992; 69: 63-68
        • Ndrepepa G.
        • Neumann F.-J.
        • Richardt G.
        • Schulz S.
        • Tolg R.
        • Stoyanov K.M.
        • et al.
        Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention.
        Circ Cardiovasc Interv. 2013; 6: 354-361
        • Trimarchi S.
        • Smith De
        • Share D.
        • Jani S.M.
        • O’Donnell M.
        • McNamara R.
        Retroperitoneal haematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
        JACC Cardiovasc Interv. 2010; 3: 845-850
        • Levine G.N.
        • Bates E.R.
        • Blankenship J.C.
        • Bailey S.R.
        • Bittl J.A.
        • Cercek B.
        ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
        Circulation. 2011; 124: 2574-2609
        • Doyle B.J.
        • Ting H.H.
        • Bell M.R.
        • Lennon R.J.
        • Mathew V.
        • Singh M.
        Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.
        J Am Coll Cardiol Intv. 2008; 1: 202-209
        • Stone G.W.
        • McLaurin B.T.
        • Cox D.A.
        • Bertrand M.E.
        • Linoff A.M.
        • Moses J.W.
        • ACUITY Investigators
        Bivalirudin for patients with acute coronary syndromes.
        N Engl J Med. 2006; 355: 2203-2216
        • Briguori C.
        • Visconti G.
        • Focaccio A.
        • Donahue M.
        • Golia B.
        • Selvetella L.
        Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting through the femoral approach. Rationale and design.
        Cardiovasc Drugs Ther. 2014; 28: 273-279
        • Pitta S.R.
        • Prasad A.
        • Kumar G.
        • Lennon R.
        • Rihal C.S.
        • Holmes D.R.
        Location of Femoral Artery Access and Correlation with Vascular Complications.
        Catheter Cardiovasc Interv. 2011; 78: 294-299
        • Schnyder G.
        • Sawhney N.
        • Whisenant B.
        • Tsimikas S.
        • Turi Z.G.
        Common femoral artery anatomy is influenced by demographics and comorbidities: implications for cardiac and peripheral invasive studies.
        Catheter Cardiovasc Interv. 2001; 53: 289-295
        • Lee M.S.
        • Applegate B.
        • Rao S.V.
        • Kirtane A.J.
        • Seto A.
        • Stone G.W.
        Minimizing femoral artery access complications during percutaneous coronary interventions: A comprehensive review.
        Catheter Cardiovasc Interv. 2014; 84: 62-69
        • Turi Z.G.
        Fluoroscopy guided vascular access: asking the right question, but getting the wrong answer?.
        Catheter Cardiovasc Interv. 2009; 74: 540-542
        • Seto A.H.
        • Abu-Fadel M.S.
        • Sparling J.M.
        • Zacharias S.J.
        • Daly T.S.
        • Harrison A.T.
        Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial).
        JACC Cardiovasc Interv. 2010; 3: 751-758
        • Ahmed B.
        • Piper W.D.
        • Malenka D.
        • VerLee P.
        • Robb J.
        • Ryan T.
        Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.
        Circ Cardiovasc Interv. 2009; 2: 423-429
      1. Fitts J, Ver LP, Hofmaster P, Malenka D. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol; 21:273–278.

        • Rafie I.M.
        • Uddin M.M.
        • Ossei-Geming N.
        • Anderson R.A.
        • Kinnaird T.D.
        Patients undergoing PCI from the femoral route by default radial operators are at high risk of vascular access-site complications.
        EuroIntervention. 2014; 9: 1189-1194
        • Patel M.R.
        • Jneid H.
        • Derdeyn C.P.
        • Klein L.W.
        • Levine G.N.
        • Lockstein R.A.
        Arteriotomy closure devices for cardiovascular procedures: A scientific statement from the American Heart Association.
        Circulation. 2010; 122: 1882-1893